Adsett Roger's Form 4 filing
INSMED Inc (INSM) · filed May 18, 2022
- Accession no.
- 0001140361-22-019782
- Filed
- May 18, 2022
- Trade date
- May 16-17, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $66.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Adsett RogerCIK 0001685904 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 16, 2022 | Common Stock | SSaleDisposed | −1,394 | $18.45 | −$25,719.3 | 148,004 | Direct | |
| May 17, 2022 | Common Stock | SSaleDisposed | −2,022 | $20.34F2 | −$41,127.48 | 145,982 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This is the weighted average sales price representing the shares sold at prices ranging from $20.21 to $20.45 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.